
Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …

It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …

Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

